ProjectInsulin

5 ms·

1. 1.▲
   by ProjectInsulin 4y ago

   yes apologies glargine was approved in 2000. And I agree it does take a while for doctors to switch. Something interesting that I have recently learned is that it may even be hard to find clinical trial participants because doctors will be
2. 2.▲
   by ProjectInsulin 4y ago

   While I don't know the answer to this in-depth I can share some bullet points and of course it depends on what country you are talking about. On top of that it is important to note that there are insulin shortages in various countries.
3. 3.▲
   by ProjectInsulin 4y ago

   Hi even the long acting insulin has been quoted to cost around $10 to manufacture (at scale)!
4. 4.▲
   by ProjectInsulin 4y ago

   Hi Francesco looks like you found me! I will respond to your email shortly :)
5. 5.▲
   by ProjectInsulin 4y ago

   I would like to point out that these fancy insulins have been around since 1996. I do agree that there is cheaper insulin available, but as others mentioned there is a significant change in quality. But I agree with you that the conversatio
6. 6.▲
   by ProjectInsulin 4y ago

   This is a great question. Simply it is a lot cheaper to make drugs in China + India. The APIs cost less, and the workforce is cheaper. With regards to regulations I don't want to generalize but it has been well documented that it is ha
7. 7.▲
   by ProjectInsulin 4y ago

   Hi as some of the others have already mentioned Lantus is off patent. My organization is focused on insulin glargine but there are generic versions of insulin lispro and aspart. Which is the generic/biosimilar version of humalog/n
8. 8.▲
   by ProjectInsulin 4y ago

   Unfortunately, this is true, and a lot of people struggle to manage their diabetes after switching to the Walmart brand. The stories I have heard generally occur to young adults who have to transition out of their parents' insurance pl
9. 9.▲
   by ProjectInsulin 4y ago

   The insulin that California would be getting from Civica Rx, at least, would be analog insulins. They are partnering together until California can make its own insulin. The biosimilars made by Mylan (Semglee) and Eli Lily (Basaglar) are bot
10. 10.▲
    by ProjectInsulin 4y ago

    Hi Rayiner, you are spot on with your analysis. My name is Eric, and my non-profit, Project Insulin, is tackling this problem head-on as well. We are developing a biosimilar insulin and will distribute it directly to patients at cost. The d